We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Early Menarche Associated with Increased Diabetes Risk

By HospiMedica International staff writers
Posted on 15 Aug 2019
A new study suggests that early onset of menstruation is associated with higher risk of type 2 diabetes mellitus (T2DM), but that the effect may be partially mediated by body mass index (BMI).

Researchers at Zhengzhou University (Zhengzhou, China) conducted a study involving 15,346 postmenopausal women participating in the Henan province rural cohort study in order to determine if early menarche (i.e., under 14 years of age) is associated with an increased risk of T2DM, and to investigate whether the association was mediated by BMI adiposity.

The results revealed that after adjusting for multiple confounders, the early menarche group had a higher risk of T2DM compared with the reference group (16-17 years of age). More...
Likewise, the late onset group (women in whom menarche occurred later that 19 years of age) had a lower risk of T2DM. The researchers also found that BMI partially mediated the association between age at menarche and T2DM, and the proportion of the effect was 28%. The study was published on July 29, 2019, in Menopause.

“This study of rural Chinese women indicates that the average age of menarche is delayed relative to western countries at 16.1 years, and is linked with lower risk of type 2 diabetes,” said Stephanie Faubion, MD, medical director of the North American Menopause Society (NAMS; Pepper Pike, OH, USA). “Earlier onset of menses was associated with diabetes in later life, likely driven by adult BMI. Other factors such as nutrition and BMI in childhood may also play a role in this association.”

Age at menarche is frequently used to explore the association between developmental tempo during puberty and disease risk. Earlier menarche has been associated with some adverse outcomes, including obesity, cardiovascular disease, some types of cancer, and mortality. Increasing rates of T2D in recent decades have occurred in parallel with a decline in the average age at menarche, with several studies reporting adverse metabolic consequences of early sexual maturation, such as increased blood glucose levels, impaired glucose tolerance, and insulin resistance. Part of the association could be explained by increased adiposity.

Related Links:
Zhengzhou University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.